STA R Max and Compact Max Coagulation Instruments
Award Notice Posted
- Solicitation number
- W81K0225FA128
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- W81K0225FA128-W81K0225FA128
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Washington, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command awarded a four-year sole source contract to Diagnostica Stago Inc. for coagulation instruments and associated reagents, consumables, and services for Madigan Army Medical Center in Tacoma, Washington. The contract provides two coagulation instruments (STA R Max and Compact Max models) that integrate with the existing Roche Diagnostics Cobas 8100 Total Laboratory Automation system to support hemostatic testing and monitor patients at risk of excessive bleeding. The award includes a base period from October 1, 2025 through September 30, 2026, followed by three option years extending through September 30, 2029, with a total contract value of $664,401.68 for the base period plus all options. Diagnostica Stago Inc. was selected as the exclusive provider capable of supplying instruments compatible with the government-owned laboratory automation system already in use at the medical facility.
Notice text
On 19 September 2025, Joint Base Lewis McChord Health Contracting Branch awarded fixed price sole source delivery order Federal Supply Schedule contract 36F797-18-D0351 to Diagnostica Stago Inc.in Parsippany, NJ for coagulation instruments and the associated reagents, consumables and services for use in hemostatic testing to assess the effectiveness of anticoagulant therapy and monitor patients at risk of excessive bleeding for Madigan Army Medical Center, Tacoma WA 98431. This award was in
accordance with FAR 8.405-6(a)(1)(i)(B). IAW FAR 5.301 this serves as the award notice under Solicitation PANHCA25P0000006440 resulting in Delivery Order W81K0225FA128. The North American Industry Classification Systems (NAICS) code for this work is 325413, with business size standard of 1,250 employees. The NAICS is for In-Vitro Diagnostic Substance Manufacturing. The Product Service Code (PSC) is 6550. The resulting contract has a base period of performance of 01 October 2025- 30 September 2026 and three (3) subsequent options periods through 30 September 2029. Total contract value of base plus options is $664,401.68. See attached J&A for further information.
Awarded contract W81K0225FA128 to DIAGNOSTICA STAGO INC for 664401.68 on 2025-09-19.
Files
| File | Type | Posted |
|---|---|---|
| 25-MRCO-P-298 FAR 8 STA R Max Coagulation_Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| STA R Max and Compact Max Coagulation Instruments | Special Notice | |
| Reagents Madigan Military Treatment Facility | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity